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Socioeconomic and Hospital-Related Predictors of
Amputation for Critical Limb Ischemia
Antonia J. Henry1, Nathanael Hevelone2, Neal R.
Barshes1, Michael Belkin1, Louis L. Nguyen1. 1Brigham
and Women’s Hospital Division of Vascular and Endo-
vascular Surgery, Boston, MA; 2Brigham and Women’s
Hospital Center for Surgery and Public Health, Boston,
MA
Objectives: Disparities in limb salvage procedures may
be driven by socioeconomic status (SES) and access to high
volume hospitals. We sought to identify SES factors asso-
ciated with major amputation in the setting of critical limb
ischemia (CLI).
Methods: The 2007 Nationwide Inpatient Sample
was queried for discharges containing lower extremity
revascularization (LER), major amputation, and chronic
CLI (N  152, 736). The Elixhauser method was used
to adjust for comorbidities. Significant predictors in
bivariate logistic regression were entered into a multivar-
iate logistic regression for the dependent variable of
amputation vs LER.
Results: Overall, 18.1% of CLI patients underwent
amputation. Significant differences were seen between both
groups in bivariate and multivariate analysis of SES factors,
including race, income, and insurance status (Table 1).
Lower income patients weremore likely to be treated at low
LER volume institutions (OR 1.44, p 0.017). Patients at
higher LER volume centers (OR 2.11, p  0.001), admit-
ted electively (OR 1.96, p  0.001) and evaluated with
diagnostic imaging (OR 4.30, p 0.001) were more likely
to receive LER.
Conclusions: After controlling for comorbidities, mi-
nority patients, those with lower SES, and patients with
Medicaid were more likely receive amputation for CLI in
low volume hospitals. Addressing SES and hospital factors
may reduce amputation rates for CLI.
Table 1. Multivariate regression for amputation
Odds Ratio for
Amputation
95% Confidence
Interval
Male gender 1.22 (p0.001) 1.13, 1.32
Black vs White race 2.33 (p0.001) 2.02, 2.69
Hispanic vs White race 1.37 (p0.001) 1.16, 1.62
Median income
\$39, 000 1.25 (p0.005) 1.08, 1.45
\$39, 000-47, 999 1.11 (p0.159) 0.96, 1.28
\$48, 000-62, 999 1.03 (p0.682) 0.88, 1.21
\$63, 000 ref
Private payer vs Medicare 0.83 (p0.002) 0.74, 0.94
Medicaid vs Medicare 1.24 (p0.015) 1.04, 1.48
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Genetic Influences on Peripheral Arterial Disease in a
Twin Population
Carl Wahlgren1, Patrik K. Magnusson2. 1Department of
Vascular Surgery, Karolinska University Hospital & Karo-
linska Institute, Stockholm, Sweden; 2Department ofMed-
ical Epidemiology and Biostatistics, Karolinska Institute,
Stockholm, Sweden
Objectives: The understanding of genetics in periph-
eral arterial disease (PAD) is still limited. The aim of this
study was to analyze the contribution of genetic and envi-
ronmental factors to the development of PAD in a large
population-based sample of twins.
Methods: The Swedish Twin Registry was cross-
linked with the Inpatient Registry, providing national
coverage of discharge diagnoses. All twins with athero-
sclerosis of extremity arteries, including claudication and
critical limb ischemia, were identified. Concordance
rates and tetrachoric correlations were calculated for
monozygotic (MZ) and dizygotic (DZ) twins. Structural
equation modeling techniques, Mx-analyses, were used
to estimate the contribution of genetic effects as well as
shared and non-shared environmental factors to devel-
opment of PAD.
Results: In the registry, 76977 twins were born
between 1886 and 1957. There were 964 twins with
PAD including 20 MZ and 22 DZ concordant pairs as
well as 216 MZ and 664 DZ discordant pairs. The
probandwise concordance rates for MZ and DZ pairs
were 15.6% and 6.2%, respectively. The tetrachoric cor-
relations were 0.52 in MZ pairs and 0.30 in DZ pairs.
The odds ratio was 16.4 (95% CI: 9.8-27.4) for MZ
twins and 5.6 (95% CI: 3.6-8.7) for DZ twins. In the
structural equation models, genetic effects accounted for
44 % (95% CI: 0.16-0.61), shared environmental effects
for 8.0 % (95% CI: 0-0.28), and non-shared environmen-
tal effects for 48% (95% CI: 0.39-0.59) of the phenotypic
variance among twins.
Conclusions: Heritability is an important component
along with unique environmental factors for development
of PAD. Concordances and correlations were higher inMZ
compared with DZ twins, indicating genetic influences in
PAD. The twin of an MZ twin with PAD had a risk of PAD
that was 16 times that of the MZ twin of a person without
PAD. A better understanding of the genetics in PAD could
identify individuals at increased risk who may benefit from
targeted therapies.
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Carotid Artery Disease and Peripheral Vascular Disease
Are Both Independent Predictors of Long-term Mor-
tality After Coronary Artery Bypass Grafting
Deva Boone1, Constantine E. Anagnostopoulos2, John
C. Lantis1, Gary S. Schwartz1, Syed S. Razi1, Daniel G.
Swistel1, Sandhya K. Balaram1, Scott J. Belsley1, Faiz Y.
Bhora1, Ioannis K. Toumpoulis2. 1St. Luke’s - Roosevelt
Hospital Center, Columbia University College of Physi-
cians and Surgeons, New York, NY; 2University of Ath-
ens School of Medicine, Attikon Hospital Center, Ath-
ens, Greece
Objectives: We examined the effects of extracoronary
artery disease on postoperative complications, 30-day mor-
tality, and long-term mortality after coronary artery bypass
grafting (CABG).
Methods: We reviewed 4766 patients who under-
went CABG at a single institution between 1992 and
2008. Preoperative and intraoperative risk factors and
postoperative complications were collected prospectively
for our state cardiac surgery database. Long-term sur-
vival data (mean follow-up 8.3 years) were obtained from
the National Death Index. Risk factors for postoperative
complications and 30-day mortality were determined by
multivariate logistic regression analysis and predictors
for long-term mortality were determined by multivariate
Cox regression analysis. Risk-adjusted Kaplan-Meier
curves were constructed and compared using the log-
rank test.
Results: Of all patients undergoing CABG, 513 pa-
tients (10.8%) had carotid artery disease and 563 patients
(11.8%) had peripheral vascular disease (PVD). Just 162
patients (3.4%) had both conditions. Postoperative compli-
cations occurred in 11.0%, with the most common compli-
cation being respiratory failure. After adjusting for other
risk factors, PVD remained an independent predictor for
postoperative complications (OR 1.42, 95% CI 1.10-1.82,
p 0.008), but carotid disease did not. Thirty-day mortal-
ity overall was 7.3%; neither carotid disease nor PVD were
associated with increased 30-day mortality after adjusting
for other risk factors. After ten years, survival for patients
without carotid disease or PVD was 70%; survival was 42%
for those with carotid disease and 38% for those with PVD.
After risk-adjustment, both carotid disease (HR 1.19, 95%
CI 1.04-1.36, p  0.01) and PVD (HR 1.41, 95% CI
1.24-1.61, p 0.001) remained independent predictors of
long-term mortality.
Conclusions: While neither carotid disease nor PVD
were associated with 30-day mortality, both were indepen-
dent predictors of long-term mortality after CABG. Only
PVD was associated with increased postoperative compli-
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Limb Salvage and Survival Rate After Endovascular
Treatment of Infrapopliteal Artery Occlusion in Di-
abetic Patients With Critical Limb Ischemia
Francesco Setacci, Pasqualino Sirignano, Francesca Ia-
coponi, Gianmarco de Donato, Emiliano Chisci, Giuseppe
Galzerano, Alessandro Cappelli, Carlo Setacci. Vascular
and Endovascular Surgery Unit, University of Siena, Siena,
Italy
Objectives: The aim of our study was to evaluate the
mid-term clinical outcomes in terms of limb salvage and
survival rate of diabetic patients affected by critical limb
ischemia due to infrapopliteal artery occlusion (CLI) un-
derwent to endovascular treatment.
Methods: The study evaluated a prospective database
of 237 diabetic patients admitted to our Vascular and
Endovascular Surgery Unit between October 2003 and
October 2006 with CLI due to infrapopliteal arterial dis-
ease. The revascularization strategy involved balloon angio-
plasty (PTA) and bail-out stenting if needed. Clinical and
duplex-scan follow-up examinations were performed after
1, 3 and 6 years and then yearly. We observed the variation
of Rutherford category, limb savage and survival rate at 1
and 3 years.
Results: We performed infrapopliteal endovascular re-
vascularization procedures in 237 patients. All of patients
were treated with PTA while only 12 (5.06%) patients
underwent bail-out stenting. At admission 62.9% of pa-
tients had Rutherford category IV, 24.9% V and 12.2% VI.
After 1 year 73% of patients jumped at least one category in
Rutherford classification. After 3 years 68.8% of these
changed the category. Limb salvage and survival rate after 1
year were 82.28% and 90.72%, respectively. After 3 years,
the same parameters were 77.22% and 79.32% (p  ns in
any case).
Conclusions: Endovascular therapy is an appealing,
safe and effective therapeutic option for the treatment of
infrapopliteal lesions in diabetic patients with CLI and can
improve their clinical outcomes.
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